首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial
被引:0
|
作者
:
Kouno, T.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Kouno, T.
[
1
]
Ando, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Ando, M.
[
1
]
Yonemori, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Yonemori, K.
[
1
]
Matsumoto, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Matsumoto, K.
[
1
]
Komiyama, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Komiyama, M.
[
1
]
Okajima, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Okajima, E.
[
1
]
Matsuoka, N.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Matsuoka, N.
[
1
]
Fujimoto, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Fujimoto, H.
[
1
]
Fujiwara, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
Fujiwara, Y.
[
1
]
机构
:
[1]
Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
来源
:
EJC SUPPLEMENTS
|
2005年
/ 3卷
/ 02期
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:246 / 247
页数:2
相关论文
共 50 条
[1]
Weekly paclitaxel (P) plus carboplatin (C) as salvage therapy in metastatic transitional cell carcinoma (TCC) of the urothelium previously treated with MVAC: Phase II trial.
Kouno, T
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Kouno, T
Ando, M
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Ando, M
Yonemori, K
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Yonemori, K
Matsumoto, K
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Matsumoto, K
Shimizu, C
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Shimizu, C
Komiyama, M
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Komiyama, M
Okajima, E
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Okajima, E
Matsuoka, N
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Matsuoka, N
Fujimoto, H
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Fujimoto, H
Fujiwara, Y
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Canc Ctr, Tokyo, Japan
Natl Canc Ctr, Tokyo, Japan
Fujiwara, Y
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005,
23
(16)
: 432S
-
432S
[2]
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
Xu, Nong
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Xu, Nong
Zhang, Xiao Chen
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Zhang, Xiao Chen
Xiong, Jian Ping
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Xiong, Jian Ping
Fang, Wei Jia
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Fang, Wei Jia
Yu, Lan Fang
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Yu, Lan Fang
Qian, Jiong
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Qian, Jiong
Zhang, Ling
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Peoples R China
Zhang, Ling
[J].
BMC CANCER,
2007,
7
(1)
[3]
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
Nong Xu
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Nong Xu
Xiao Chen Zhang
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Xiao Chen Zhang
Jian Ping Xiong
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Jian Ping Xiong
Wei Jia Fang
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Wei Jia Fang
Lan Fang Yu
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Lan Fang Yu
Jiong Qian
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Jiong Qian
Ling Zhang
论文数:
0
引用数:
0
h-index:
0
机构:
Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
Ling Zhang
[J].
BMC Cancer,
7
[4]
Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
Johannsen, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Johannsen, M
Sachs, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Sachs, M
Roigas, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Roigas, J
Hinke, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Hinke, A
Staack, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Staack, A
Loening, SA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Loening, SA
Schnorr, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Schnorr, D
Wille, AH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Med Berlin, Charite, Dept Urol, D-10117 Berlin, Germany
Wille, AH
[J].
EUROPEAN UROLOGY,
2005,
48
(02)
: 246
-
251
[5]
Phase II study of Taxol (paclitaxel) and Carboplatin in patients with advanced transitional-cell carcinoma of the urothelium (TCC)
Mottet, N
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Mottet, N
Prapotnich, D
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Prapotnich, D
Beuzeboc, P
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Beuzeboc, P
Di Palma, M
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Di Palma, M
Bui, N
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Bui, N
Eymard, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Eymard, JC
Mercat, A
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Mercat, A
Garet, F
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Garet, F
Droz, JP
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Mutualiste Montsouris, Paris, France
Droz, JP
[J].
ANNALS OF ONCOLOGY,
1998,
9
: 59
-
59
[6]
Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer
Wille, AH
论文数:
0
引用数:
0
h-index:
0
Wille, AH
Johannsen, M
论文数:
0
引用数:
0
h-index:
0
Johannsen, M
Roigas, J
论文数:
0
引用数:
0
h-index:
0
Roigas, J
Schnorr, DR
论文数:
0
引用数:
0
h-index:
0
Schnorr, DR
[J].
JOURNAL OF UROLOGY,
2003,
169
(04):
: 380
-
381
[7]
A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
von der Maase, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
von der Maase, H.
Lehmann, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Lehmann, J.
Gravis, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Gravis, G.
Joensuu, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Joensuu, H.
Geertsen, P. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Geertsen, P. F.
Gough, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Gough, J.
Chen, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Chen, G.
Kania, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Kania, M.
[J].
ANNALS OF ONCOLOGY,
2006,
17
(10)
: 1533
-
1538
[8]
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
Hainsworth, JD
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Hainsworth, JD
Meluch, AA
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Meluch, AA
Litchy, S
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Litchy, S
Schnell, FM
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Schnell, FM
Bearden, JD
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Bearden, JD
Yost, K
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Yost, K
Greco, FA
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, PLLC, Nashville, TN 37203 USA
Greco, FA
[J].
CANCER,
2005,
103
(11)
: 2298
-
2303
[9]
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium:: A phase II clinical trial
von der Maase, H
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
von der Maase, H
Andersen, L
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Andersen, L
Crinò, L
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Crinò, L
Weinknecht, S
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Weinknecht, S
Dogliotti, L
论文数:
0
引用数:
0
h-index:
0
机构:
Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
Dogliotti, L
[J].
ANNALS OF ONCOLOGY,
1999,
10
(12)
: 1461
-
1465
[10]
Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage
Santoro, A
论文数:
0
引用数:
0
h-index:
0
机构:
San Gennaro Hosp, OU Med Oncol, Naples, Italy
Santoro, A
Santoro, M
论文数:
0
引用数:
0
h-index:
0
机构:
San Gennaro Hosp, OU Med Oncol, Naples, Italy
Santoro, M
Maiorino, L
论文数:
0
引用数:
0
h-index:
0
机构:
San Gennaro Hosp, OU Med Oncol, Naples, Italy
Maiorino, L
Forestieri, V
论文数:
0
引用数:
0
h-index:
0
机构:
San Gennaro Hosp, OU Med Oncol, Naples, Italy
Forestieri, V
Forestieri, P
论文数:
0
引用数:
0
h-index:
0
机构:
San Gennaro Hosp, OU Med Oncol, Naples, Italy
Forestieri, P
[J].
ANNALS OF ONCOLOGY,
1998,
9
: 169
-
169
←
1
2
3
4
5
→